phosphorylcholine has been researched along with pd 98059 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurabayashi, M; Nagai, R; Okajima, F; Sekiguchi, K; Yokoyama, T | 1 |
Mullan, M; Paris, D; Town, T | 1 |
Ahn, DS; Cho, YE; Choi, SK; Kim, YH; Lee, YH; Morgan, KG; Ryu, SK | 1 |
Huh, CH; Kim, DS; Kwon, SB; Park, ES; Park, KC; Park, SH; Youn, SW | 1 |
Back, SJ; Kim, CD; Kwon, YB; Lee, JH; Lee, YS; Park, JK; Piao, YJ; Seo, YJ; Sohn, KC; Suhr, KB | 1 |
Bezouglaia, O; Demer, LL; Huang, MS; Lu, J; Morony, S; Tetradis, S; Tintut, Y; Tseng, W; Zhang, Z | 1 |
Jeong, HS; Kim, DS; Park, KC | 1 |
Byun, HJ; Kang, GJ; Kim, EJ; Kim, HJ; Lee, CH; Lee, H; Nam, S; Park, MK | 1 |
8 other study(ies) available for phosphorylcholine and pd 98059
Article | Year |
---|---|
Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes.
Topics: Adrenergic beta-Agonists; Animals; Animals, Newborn; Cell Size; Endothelin-1; Enzyme Inhibitors; Flavonoids; GTP-Binding Proteins; Heart; Hypertrophy; Isoproterenol; MAP Kinase Signaling System; Muscle Proteins; Myocardium; Pertussis Toxin; Phosphorylation; Phosphorylcholine; Protein Processing, Post-Translational; Rats; Sphingosine; Virulence Factors, Bordetella | 1999 |
Novel strategies for opposing murine microglial activation.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Cells, Cultured; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dipyridamole; Enzyme Inhibitors; Flavonoids; Guanylate Cyclase; Imidazoles; Indazoles; Isoenzymes; Lipopolysaccharides; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mice; Microglia; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phospholipases A2; Phosphorylcholine; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; Signal Transduction; Tumor Necrosis Factor-alpha | 2000 |
Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat.
Topics: Amides; Animals; Calcium; Flavonoids; Hypertension; Mesenteric Arteries; Mitogen-Activated Protein Kinases; Myosin Light Chains; Naphthalenes; Phosphorylation; Phosphorylcholine; Protein Kinase C; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; rho-Associated Kinases; Sphingosine; Vasoconstriction | 2006 |
Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes.
Topics: Antioxidants; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Male; MAP Kinase Signaling System; Melanins; Melanocytes; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Phosphorylcholine; Pigmentation; Pyrones; Ribosomal Protein S6 Kinases, 90-kDa; Sphingosine | 2006 |
Sphingosylphosphorylcholine-induced interleukin-6 production is mediated by protein kinase C and p42/44 extracellular signal-regulated kinase in human dermal fibroblasts.
Topics: Animals; Cells, Cultured; Dermis; Dose-Response Relationship, Drug; Enzyme Activation; Epidermis; Fibroblasts; Flavonoids; Humans; Indoles; Interleukin-6; Maleimides; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Phosphorylcholine; Protein Kinase C; Protein Kinase C-alpha; Protein Kinase Inhibitors; Rabbits; RNA, Messenger; Sphingosine; Tetradecanoylphorbol Acetate; Time Factors; Transfection; Wound Healing | 2007 |
Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts.
Topics: Animals; Atherosclerosis; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; DNA-Binding Proteins; Enzyme Inhibitors; Flavonoids; Mice; Nuclear Receptor Subfamily 4, Group A, Member 2; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Parathyroid Hormone; Phosphatidylcholines; Phospholipids; Phosphorylcholine; Signal Transduction; Transcription Factors; Transforming Growth Factor beta | 2007 |
PP2A and DUSP6 are involved in sphingosylphosphorylcholine-induced hypopigmentation.
Topics: Animals; Cell Line; Dual Specificity Phosphatase 6; Enzyme Activation; Enzyme Activators; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Hypopigmentation; MAP Kinase Signaling System; Melanins; Mice; Phosphorylation; Phosphorylcholine; Protein Phosphatase 2; Protein Processing, Post-Translational; Sphingosine | 2012 |
Novel effects of sphingosylphosphorylcholine on invasion of breast cancer: Involvement of matrix metalloproteinase-3 secretion leading to WNT activation.
Topics: Breast Neoplasms; Caproates; Cell Line, Tumor; Female; Flavonoids; Gene Silencing; Humans; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Phosphorylcholine; Polycyclic Compounds; Sphingosine; Valine; Wnt Signaling Pathway | 2016 |